Research progress on the improvement mechanism of active ingredients of <italic style="font-style: italic">Swertia mussotii </italic>on metabolic syndrome

WU Tao; LIU Li; SONG Hongping

doi:10.6039/j.issn.1001-0408.2024.15.22

您当前的位置：

首页 >

文章列表页 >

Research progress on the improvement mechanism of active ingredients of Swertia mussotii on metabolic syndrome

更新时间：2024-08-11

- Research progress on the improvement mechanism of active ingredients of Swertia mussotii on metabolic syndrome
- ZHONGGUO YAOFANG Vol. 35, Issue 15, Pages: 1928-1932(2024)
- 作者机构：
  
  武汉市第四医院药学部，武汉　430033
- 作者简介：
- 基金信息：
- DOI：10.6039/j.issn.1001-0408.2024.15.22
  CLC： R965;R285.5
- Published：15 August 2024，
  
  Received：10 January 2024，
  
  Revised：22 June 2024，
- 稿件说明：
扫描看全文
吴涛,刘立,宋红萍.藏茵陈有效成分改善代谢综合征的作用机制研究进展 ^Δ[J].中国药房,2024,35(15):1928-1932.

WU Tao,LIU Li,SONG Hongping.Research progress on the improvement mechanism of active ingredients of Swertia mussotii on metabolic syndrome[J].ZHONGGUO YAOFANG,2024,35(15):1928-1932.
吴涛,刘立,宋红萍.藏茵陈有效成分改善代谢综合征的作用机制研究进展 ^Δ[J].中国药房,2024,35(15):1928-1932. DOI： 10.6039/j.issn.1001-0408.2024.15.22.

WU Tao,LIU Li,SONG Hongping.Research progress on the improvement mechanism of active ingredients of Swertia mussotii on metabolic syndrome[J].ZHONGGUO YAOFANG,2024,35(15):1928-1932. DOI： 10.6039/j.issn.1001-0408.2024.15.22.

摘要

代谢综合征（MS）是以肥胖、糖脂代谢异常以及高血压为主要特征的临床症候群。藏茵陈是我国藏族民间常用药，其功效与MS病机吻合，对MS具有对症治疗潜力。本文对藏茵陈有效成分改善MS的作用机制进行总结发现，龙胆苦苷、獐牙菜苷、獐牙菜苦苷、芒果苷、齐墩果酸等有效成分可通过调节糖脂代谢、改善肥胖、调节心血管系统、抗慢性炎症、抗氧化应激、抗内质网应激、调节自噬、调节肠道菌群紊乱，发挥改善MS的作用。

Abstract

Metabolic syndrome （MS） is a complex group of clinical syndromes with obesity， abnormal glucose and lipid metabolism and hypertension as the main clinical features.

Swertia mussotii

is a commonly used medicine among the Tibetan people in China. Its efficacy is consistent with the pathogenesis of MS， which has the potential for symptomatic treatment of MS. It is found that effective ingredients such as gentiopicroside， sweroside， swertiamarin， mangiferin， and oleanolic acid can improve MS by regulating glucose and lipid metabolism， improving obesity， regulating the cardiovascular system， inhibiting chronic inflammation， oxidative stress， endoplasmic reticulum and autophagy， and improving intestinal microflora disorder.

关键词

藏茵陈有效成分代谢综合征肥胖糖脂代谢作用机制

Keywords

active ingredientsmetabolic syndromeobesityglucose and lipid metabolismmechanism of action

references

ALEMANY M. The metabolic syndrome，a human disease[J]. Int J Mol Sci，2024，25（4）：2251.

刘莹，田成旺，张铁军.藏茵陈的药理与临床研究进展[J].现代药物与临床，2010，25（5）：345-348，368.

LIU Y，TIAN C W，ZHANG T J. Progress in pharmacological actions and clinical applications of Zangyinchen[J]. Drugs & Clinic，2010，25（5）：345-348，368.

马丽娜·阿新拜，杨一点，张欢，等. 基于潜在类别分析和隐结构分析探究代谢综合征中医证候类型分布特点[J]. 北京中医药大学学报，2024，47（4）：532-544.

Malina·Axinbai，YANG Y D，ZHANG H，et al. Characte- ristics of traditional Chinese medicine pattern distribution of metabolic syndrome based on latent class analysis and latent structure analysis[J]. J Beijing Univ Tradit Chin Med，2024，47（4）：532-544.

ZAFAR U，KHALIQ S，AHMAD H U，et al. Metabolic syndrome：an update on diagnostic criteria，pathogenesis，and genetic links[J]. Hormones，2018，17（3）：299-313.

韵海霞，陈志. 川西獐牙菜的研究进展[J]. 华西药学杂志，2020，35（5）：567-571.

YUN H X，CHEN Z. Research progress of Swertia mussotii[J]. West China J Pharm Sci，2020，35（5）：567-571.

林泊然，孙钟毓，聂磊，等. 藏茵陈化学成分和药理作用研究及质量标志物预测分析[J]. 中华中医药学刊，2023，41（12）：99-107.

LIN B R，SUN Z Y，NIE L，et al. Research progress on chemical constituents and pharmacological effects of Zangyinchen（Swertia mussotii） and prediction analysis on its quality markers[J]. Chin Arch Tradit Chin Med，2023，41（12）：99-107.

缪美琪，韩宇博，刘莉. 黄连温胆汤防治代谢综合征研究进展[J]. 辽宁中医药大学学报，2023，25（8）：35-39.

MIAO M Q，HAN Y B，LIU L. Research progress of Huanglian wendan decoction in the prevention and treatment of metabolic syndrome[J]. J Liaoning Univ Tradit Chin Med，2023，25（8）：35-39.

温授惠，宋阳，何杰，等. 藏茵陈环烯醚萜类化合物改善油酸诱导的肝细胞脂肪变性[J]. 烟台大学学报（自然科学与工程版），2023，36（3）：285-293.

WEN S H，SONG Y，HE J，et al. Oleic acid-induced hepatocyte steatosis improved by iridoids of Zangyinchen[J]. J Yantai Univ Nat Sci Eng Ed，2023，36（3）：285-293.

YANG Y，LI J，WEI C，et al. Amelioration of nonalcoholic fatty liver disease by swertiamarin in fructose-fed mice[J]. Phytomedicine，2019，59：152782.

SARKAR P，BHOWMICK A，KALITA M C，et al. Effects of resveratrol and mangiferin on PPARγ and FALDH gene expressions in adipose tissue of streptozotocin-nicotinamide-induced diabetes in rats[J]. J Diet Suppl，2019，16（6）：659-675.

LIU Z B，APONTES P，FOMENKO E V，et al. Mangi- ferin accelerates glycolysis and enhances mitochondrial bioenergetics[J]. Int J Mol Sci，2018，19（1）：201.

SINGH A K，RAJ V，KESHARI A K，et al. Isolated mangiferin and naringenin exert antidiabetic effect via PPARγ/GLUT4 dual agonistic action with strong metabolic regulation[J]. Chem Biol Interact，2018，280：33-44.

WANG H L，HE X，LEI T T，et al. Mangiferin induces islet regeneration in aged mice through regulating p16INK4a[J]. Int J Mol Med，2018，41（6）：3231-3242.

ZHANG Q，KONG X J，YUAN H，et al. Mangiferin improved palmitate-induced-insulin resistance by promoting free fatty acid metabolism in HepG2 and C2C12 cells via PPARα：mangiferin improved insulin resistance[J]. J Diabetes Res，2019，2019：2052675.

WANG X，LONG D M，HU X H，et al. Gentiopicroside modulates glucose homeostasis in high-fat-diet and streptozotocin-induced type 2 diabetic mice[J]. Front Pharmacol，2023，14：1172360.

XIAO H M，SUN X H，LIN Z Y，et al. Gentiopicroside targets PAQR3 to activate the PI3K/Akt signaling pathway and ameliorate disordered glucose and lipid metabolism[J]. Acta Pharm Sin B，2022，12（6）：2887-2904.

LIU Y，HU Z J，XING H Y，et al. Renoprotective effects of oleanolic acid and its possible mechanisms in rats with diabetic kidney disease[J]. Biochem Biophys Res Commun，2022，636（Pt 1）：1-9.

WANG S，DU L B，JIN L，et al. Nano-oleanolic acid alleviates metabolic dysfunctions in rats with high fat and fructose diet[J]. Biomed Pharmacother，2018，108：1181-1187.

GAMEDE M，MABUZA L，NGUBANE P，et al. Plant-derived oleanolic acid ameliorates markers associated with non-alcoholic fatty liver disease in a diet-induced pre-diabetes rat model[J]. Diabetes Metab Syndr Obes，2019，12：1953-1962.

XUE C Y，LI Y，LV H，et al. Oleanolic acid targets the gut-liver axis to alleviate metabolic disorders and hepatic steatosis[J]. J Agric Food Chem，2021，69（28）：7884-7897.

阮君，尚浩南，刘雨，等. 利胆化痰活血方对代谢综合征大鼠肥胖相关指标的药效学影响[J]. 西部中医药，2023，36（8）：11-14.

RUAN J，SHANG H N，LIU Y，et al. Pharmacodynamic effects of Lidan huatan huoxue prescription on obesity-related indexes in rats with metabolic syndrome[J]. West J Tradit Chin Med，2023，36（8）：11-14.

ZHU Y Q，LI H R，MA M C，et al. Swertiamarin ameliorates diet-induced obesity by promoting adipose tissue browning and oxidative metabolism in preexisting obese mice[J]. Acta Biochim Biophys Sin （Shanghai），2022，55（1）：131-142.

YANG Q L，SHU F F，GONG J T，et al. Sweroside ameliorates NAFLD in high-fat diet induced obese mice through the regulation of lipid metabolism and inflammatory response[J]. J Ethnopharmacol，2020，255：112556.

CHOI R Y，NAM S J，LEE H I，et al. Gentiopicroside isolated from Gentiana scabra Bge. inhibits adipogenesis in 3T3-L1 cells and reduces body weight in diet-induced obese mice[J]. Bioorg Med Chem Lett，2019，29（14）：1699-1704.

ZARASVAND S A，HALEY-ZITLIN V，OLADOSU O，et al. Assessing anti-adipogenic effects of mango leaf tea and mangiferin within cultured adipocytes[J]. Diseases，2023，11（2）：70.

LEONG X Y，THANIKACHALAM P V，PANDEY M， et al. A systematic review of the protective role of swertiamarin in cardiac and metabolic diseases[J]. Biomed Pharmacother，2016，84：1051-1060.

YANG H，BAI W W，GAO L H，et al. Mangiferin allevia-tes hypertension induced by hyperuricemia via increasing nitric oxide releases[J]. J Pharmacol Sci，2018，137（2）：154-161.

CHAKRABORTY R，ROY S. Angiotensin-converting enzyme inhibitors from plants：a review of their diversity，modes of action，prospects，and concerns in the management of diabetes-centric complications[J]. J Integr Med，2021，19（6）：478-492.

GAMEDE M，MABUZA L，NGUBANE P，et al. Plant-derived oleanolic acid （OA） ameliorates risk factors of cardiovascular diseases in a diet-induced pre-diabetic rat model：effects on selected cardiovascular risk factors[J]. Molecules，2019，24（2）：340.

EMANUELA F，GRAZIA M，MARCO DE R，et al. Inflammation as a link between obesity and metabolic syndrome[J]. J Nutr Metab，2012，2012：476380.

XU L，LI D D，ZHU Y Q，et al. Swertiamarin supplementation prevents obesity-related chronic inflammation and insulin resistance in mice fed a high-fat diet[J]. Adipocyte，2021，10（1）：160-173.

ZHANG Y，WANG R Q，YAO H J，et al. Mangiferin ameliorates HFD-induced NAFLD through regulation of the AMPK and NLRP3 inflammasome signal pathways[J]. J Immunol Res，2021，2021：4084566.

LI W Q，ZENG H X，XU M，et al. Oleanolic acid improves obesity-related inflammation and insulin resistance by regulating macrophages activation[J]. Front Pharmacol，2021，12：697483.

TAN X Q，LIANG Z B，LI Y G，et al. Isoorientin，a GSK-3β inhibitor，rescues synaptic dysfunction，spatial memory deficits and attenuates pathological progression in APP/PS1 model mice[J]. Behav Brain Res，2021，398：112968.

WANG T，WU S B，IBRAHIM I A A，et al. Cardioprotective role of swertiamarin，a plant glycoside against experimentally induced myocardial infarction via antioxidant and anti-inflammatory functions[J]. Appl Biochem Biotechnol，2023，195（9）：5394-5408.

WU T，LI J J，LI Y，et al. Antioxidant and hepatoprotective effect of swertiamarin on carbon tetrachloride-induced hepatotoxicity via the Nrf2/HO-1 pathway[J]. Cell Physiol Biochem，2017，41（6）：2242-2254.

王保，姚嘉茵，尧新华，等. 獐牙菜苦苷可减轻糖尿病大鼠的周围神经痛：基于抑制NOXS/ROS/NLRP3通路实验[J]. 南方医科大学学报，2021，41（6）：937-941.

WANG B，YAO J Y，YAO X H，et al. Swertiamarin alle- viates diabetic peripheral neuropathy in rats by suppres- sing NOXS/ROS/NLRP3 signal pathway[J]. J South Med Univ，2021，41（6）：937-941.

FAN X Y，WEI W，HUANG J B，et al. Isoorientin attenuates cisplatin-induced nephrotoxicity through the inhibition of oxidative stress and apoptosis via activating the SIRT1/SIRT6/Nrf-2 pathway[J]. Front Pharmacol，2020，11：264.

NYAKUDYA T T，ISAIAH S，AYELESO A，et al. Short-term neonatal oral administration of oleanolic acid protects against fructose-induced oxidative stress in the skeletal muscles of suckling rats[J]. Molecules，2019，24（4）：661.

LI S X，JIN S H，CHEN W L，et al. Mangiferin alleviates endoplasmic reticulum stress in acute liver injury by regulating the miR-20a/miR-101a-Nrf2 axis[J]. J Biochem，2020，168（4）：365-374.

CHEN F，WANG N，TIAN X Y，et al. The protective effect of mangiferin on formaldehyde-induced HT22 cell damage and cognitive impairment[J]. Pharmaceutics，2023，15（6）：1568.

ZHANG Q P，CHEN W Y，ZHANG B Y，et al. Central role of TRAP1 in the ameliorative effect of oleanolic acid on the mitochondrial-mediated and endoplasmic reticulum stress-excitated apoptosis induced by ochratoxin A[J]. Toxicology，2021，450：152681.

MA L Q，YU Y，CHEN H，et al. Sweroside alleviated aconitine-induced cardiac toxicity in H9c2 cardiomyoblast cell line[J]. Front Pharmacol，2018，9：1138.

DING Y，CHEN Y F，HU K，et al. Sweroside alleviates hepatic steatosis in part by activating AMPK/mTOR-mediated autophagy in mice[J]. J Cell Biochem，2023，124（7）：1012-1022.

HOU J，ZHENG D Z，XIAO W J，et al. Mangiferin enhanced autophagy via inhibiting mTORC1 pathway to prevent high glucose-induced cardiomyocyte injury[J]. Front Pharmacol，2018，9：383.

NOH J W，LEE H Y，LEE B C. Mangiferin ameliorates obesity-associated inflammation and autophagy in high-fat-diet-fed mice：in silico and in vivo approaches[J]. Int J Mol Sci，2022，23（23）：15329.

CHEN J，CUI Y M，ZHANG N，et al. Oleanolic acid attenuated diabetic mesangial cell injury by activation of autophagy via miRNA-142-5p/PTEN signaling[J]. Cytotechnology，2019，71（5）：925-933.

HE Z Y，ZHU H Y，LIU J H，et al. Mangiferin alleviates trimethylamine-N-oxide （TMAO）-induced atherogenesis and modulates gut microbiota in mice[J]. Food Funct，2023，14（20）：9212-9225.

XUE C Y，LV H，LI Y，et al. Oleanolic acid reshapes the gut microbiota and alters immune-related gene expression of intestinal epithelial cells[J]. J Sci Food Agric，2022，102（2）：764-773.

YUAN L，LI X Y，HE S Y，et al. Effects of natural flavonoid isoorientin on growth performance and gut microbiota of mice[J]. J Agric Food Chem，2018，66（37）：9777-9784.

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Research progress on the intervention of traditional Chinese medicine in renal interstitial fibrosis based on PI3K/Akt signaling pathway

Research progress of traditional Chinese medicine regulating related signaling pathways to promote tendon-bone healing

Research progress about traditional Chinese medicine in the intervention of gastric cancer by regulating Th17/Treg balance

Research progress on anti-pulmonary fibrosis effect and mechanism of flavonoids

Study on the mechanism of Chonghe paste promoting the dissipation of swollen lesions in vivo and in vitro

Related Author

LI Xue

ZHANG Yunlong

SONG Ziyi

ZHANG Zhujiang

YANG Chao

REN Tianjiao

JIA Linzhen

YANG Chaoqiang

Related Institution

School of Pharmacy， Qiqihar Medical College

School of Medical Technology， Qiqihar Medical College

School of Stomatology， Qiqihar Medical College

School of Public Health， Qiqihar Medical College

Heilongjiang Provincial Key Laboratory of Medicine-Food Homologous Resources and Metabolic Disease Prevention and Control

Address：8th Floor, Sihuan Building, No. 129 Daping Main Street, Yuzhong District, Chongqing, China Postal code：400042
Technical support is provided by Beijing Founder Electronics co., LTD 渝ICP备15012710号公网安备50010302001817
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰

Research progress on the improvement mechanism of active ingredients of Swertia mussotii on metabolic syndrome

DOI：10.6039/j.issn.1001-0408.2024.15.22

摘要

Abstract

关键词

Keywords

references